Know the rules The Paceline Forum Builder's Spotlight


Go Back   The Paceline Forum > General Discussion

 
 
Thread Tools Display Modes
Prev Previous Post   Next Post Next
  #29  
Old Yesterday, 06:47 PM
flying flying is offline
Senior Member
 
Join Date: Dec 2018
Posts: 2,206
These days folks like Pere Attia prefer Repatha (PSK9 inhibitor), Ezetimibe / Zetia(cholesterol absorption blocker) or bempedoic acid (works in liver to reduce cholesterol production)

You kind of need to know if you are a excessive cholesterol producer or absorber

Then they have a drug called Nexlizet which has both Ezetimibe & Bempedoic acid in it. Which basically addresses both production & absorption I guess

So those three things are the new drugs which are not statins & for teh most part have no side effects for most people

Repatha & Nexlizet can be expensive if your insurance wont cover but if your doctor states you do not tolerate statins they allow it.

But lastly a very interesting thing about Statins is they have found (but don't advertise it) That Statins benefits are gained 80-85% with a 25% dosage

That means a low dosage & many folks report amazing results with no side effects & these were folks that could not tolerate them. But that was due to being heavily dosed

Many practitioners prescribe crazy high dosages like 40-80mg where in reality many folks get by on 5-10mg with great cholesterol lower effects. Some folks go 1.5mg a day & some even every other day

Something to think about?

That aside things like Berberine which is a natural form of PSK9 inhibitor is something to look at.

Last but not least we can help ourselves a lot by cleaning up our diets. Takes time but works well
Reply With Quote
 


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -5. The time now is 07:29 AM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.